Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer.
Sefrioui, David
Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer. [electronic resource] - International journal of cancer Nov 2015 - 2513-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-0215
10.1002/ijc.29612 doi
Aromatase Inhibitors--therapeutic use
Breast Neoplasms--drug therapy
DNA, Neoplasm--blood
Drug Resistance, Neoplasm
Estrogen Receptor alpha--genetics
Female
Humans
Mutation
Neoplasm Metastasis
Neoplastic Cells, Circulating--pathology
Polymerase Chain Reaction--methods
Retrospective Studies
Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer. [electronic resource] - International journal of cancer Nov 2015 - 2513-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1097-0215
10.1002/ijc.29612 doi
Aromatase Inhibitors--therapeutic use
Breast Neoplasms--drug therapy
DNA, Neoplasm--blood
Drug Resistance, Neoplasm
Estrogen Receptor alpha--genetics
Female
Humans
Mutation
Neoplasm Metastasis
Neoplastic Cells, Circulating--pathology
Polymerase Chain Reaction--methods
Retrospective Studies